Abdel-Baset Halim
Director, Department of Clinical Biomarkers
Daiichi Sankyo Pharma Development, USA
Abdel Halim is a nationally recognized biomarker and clinical laboratory professional with more than 25 years of experience in all aspects of biomarker discovery, development, validation, and applications in patient management and pharmaceutical development. He is an expert in all biomarker techniques and platforms including DNA based technologies.
Expert in all aspects of biomarkers; discovery, development, validation, and applications in pharmaceutical trials safety, proof-of-concept, proof of mechanism, pharmacodynamics, predictive, prognostic, immunohistochemistry, in situ hybridization, circulating tumor cells, proteomics, circulating DNA, metabolomics, etc.